Jennifer L Miller, MD - Research

Research at a glance

Top areas of exploration

Prader-Willi Syndrome , 48 publications
Hyperphagia , 8 publications
Chromosomes, Human, Pair 15 , 8 publications
Obesity , 7 publications

Research activity

68 publications

3,045 citations

Focus

My research focuses on investigation of the etiology and possible treatment for obesity and metabolic abnormalities in individuals with Prader-Willi syndrome and early-onset obesity. I have been working towards achieving an appropriate treatment for hyperphagia for the past 12 years. I currently follow over 500 patients with Prader-Willi syndrome from around the world, and over 100 patients with early-onset obesity due to other genetic causes. I am working on clinical treatment trials to treat hyperphagia in individuals with Prader-Willi syndrome and early-onset obesity..

Active clinical trials

RM-493-042

This is an open-label extension study designed to evaluate the long-term safety and tolerability of continued setmelanotide treatment in male and female patients 鈮�2 years of age who have completed or transitioned from a previous study with鈥�

Investigator: Jennifer L Miller
Status: Accepting Candidates
Ages: 2 Years - N/A
Sexes: All

RM-493-040

Investigator: Jennifer L Miller
Status: Accepting Candidates

C614

The purpose of this is study is to evaluate the long-term safety of DCCR (diazoxide choline) extended-release tablets) in patients with Prader-Willi syndrome.

Investigator: Jennifer L Miller
Status: Accepting Candidates
Ages: 4 Years - N/A
Sexes: All

My publications

68 publications

2024

Behavioral changes in patients with Prader-Willi syndrome receiving diazoxide choline extended-release tablets compared to the PATH for PWS natural history study.

Journal of neurodevelopmental disorders

鈥�

2024

Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: results from long-term open-label study.

Obesity (Silver Spring, Md.)

鈥�

2024

Neuromodulation for the treatment of Prader-Willi syndrome - A systematic review.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

鈥�

2023

Diazoxide Choline Extended-Release Tablet in People With Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial

The Journal of Clinical Endocrinology & Metabolism

鈥�

2023

Hyperinsulinemia is a probable trigger for weight gain and hyperphagia in individuals with Prader-Willi syndrome.

Obesity science & practice

鈥�

BOB体育